The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
08/11/2016 | Managing Intellectual Property Blog
1 min
March 18, 2025
March 12, 2025
March 03, 2025
3/24/2025
March 19, 2025
March 17, 2025
March 14, 2025